Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma
Susanne Holck,
Louise Laurberg Klarskov
, Lars-Inge Larsson
Department of Clinical Medicine
4
Citations (Scopus)
15
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chemotherapy
100%
Phospho-ERK
100%
Colorectal Cancer
66%
Preoperative Chemotherapy
50%
Clinical High Risk
33%
Cancer Cells
33%
ERK1
16%
ERK2
16%
Signaling Molecules
16%
Upstream Regulator
16%
Prognostic Groups
16%
Cancer Growth
16%
High Risk
16%
Recurrence-free Survival
16%
Phosphorylation
16%
Cancer Progression
16%
In Vitro Study
16%
Poor Response
16%
Neoadjuvant
16%
Poor Prognostic
16%
Apoptosis
16%
Predictive Marker
16%
EGF Receptor
16%
Cellular Level
16%
Radiochemotherapy
16%
Medicine and Dentistry
Rectum Carcinoma
100%
Rectum Cancer
100%
Cancer Cell
50%
Cancer Growth
50%
Chemoradiotherapy
50%
Programmed Cell Death
25%
Mitogen Activated Protein Kinase 3
25%
Mitogen Activated Protein Kinase 1
25%
Epidermal Growth Factor Receptor
25%
Fluorouracil
25%
Predictive Marker
25%
In Vitro
25%
Recurrence Free Survival
25%
Signaling Molecule
25%
Pharmacology, Toxicology and Pharmaceutical Science
Rectum Cancer
100%
Rectum Carcinoma
100%
Chemotherapy
100%
Cancer Growth
50%
Malignant Neoplasm
25%
Recurrence Free Survival
25%
Epidermal Growth Factor Receptor
25%
Mitogen Activated Protein Kinase 1
25%
Fluorouracil
25%
Mitogen Activated Protein Kinase 3
25%
Immunology and Microbiology
Cancer Cell
100%
Cell Level
50%
Recurrence Free Survival
50%
Programmed Cell Death
50%